Retinoid receptors in transcriptional regulation

Current Opinion in Genetics and Development

Volumn 6, Issue 5, 1996, Pages 567-574

  Minucci, Saverio ^a   Ozato, Keiko ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN RECEPTOR;

ALLOSTERISM; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR INTERACTION; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0030271711     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)80085-2     Document Type: Article

References (67)

1. Sporn MB, Roberts AB, Goodman DS. edn 1 The Retinoids, 1994;Raven Press, New York.
2. Chambon P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol. 5:1994;115-125.
3. Mangeldorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
4. Heyman RA, Mangelsdorf DJ, Dick JA, Stein RB, Eichele G, Evans RM, Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:1992;397-406.
5. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR. Nature. 355:1992;359-361.
6. Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, Levin A. Retinoic acid receptors and retinoid X receptors; interactions with endogenous retinoic acids. Proc Natl Acad Sci USA. 90:1993;30-34.
7. Glass CK. Differential recognition of target genes by nuclear receptors monomers, dimers and heterodimers. Endocrinol Rev. 15:1994;391-407.
8. Leblanc B, Stunnenberg HG. 9-cis retinoic acid signaling: changing partners causes some excitement. Genes Dev. 9:1995;1811-1816.
9. Tsai M-J, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 63:1994;451-486.
10. Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell. 83:1995;851-857.
11. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their roles in real life? Cell. 83:1995;859-871.
12. Keaveney M, Stunnenberg H. Retinoic acid receptors. Bäuerle PA. Inducible Gene Expression. 1995;187-242 Birkhäuser, Boston.
13. Manglesdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans P. The nuclear hormone receptor superfamily: the second decade. Cell. 83:1995;835-840.
14. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α of outstanding interest Nature. 375:1995;377-382 The paper reports the X-ray structure of apo-RXR LBD, with the novel folding shown for the LBD. As further analyzed in [17], it seems likely that this fold, like that for the DBD, is common throughout the nuclear receptor family.
15. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D. Crystal structure of the RARγ ligand binding domain bound to all-trans retinoic acid. of outstanding interest Nature. 378:1995;681-690 This paper shows the X-ray structure of holo-RARγ LBD. By comparing the structure of the previously resolved holo-RXR LDB, the authors propose that, upon ligand binding, the carboxy-terminal part (AF-2) folds back to the core of the LDB.
16. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. of outstanding interest Nature. 378:1995;690-697 This paper reports the X-ray structure of holo-TRα LDB, revealing a number of shared features with that of holo-RARγ.
17. of outstanding interest Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. of special interest Nat Struct Biol. 3:1996;87-94 By extensive sequence analysis, the authors propose the preence of a common fold for the nuclear receptor LBD (see also [14, 16]).
18. Schwabe JWR. How nuclear receptors get turned on. Curr Biol. 6:1996;372-374.
19. Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai M-J, O'Malley BW. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem. 267:1992;19513-19520.
20. Len X, Tsai SY, O'Malley BW, Tsai MJ. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. J Steroid Biochem Molec Biol. 46:1993;643-661.
21. Keidel S, LeMotte P, Apfel C. Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol Cell Biol. 14:1994;287-298.
22. Leid M. Ligand-induced alteration of the protease sensitivity of retinoid X receptor alpha. J Biol Chem. 269:1994;14175-14181.
23. Leng X, Blanco J, Tsai SY, Ozato K, O'Malley BW, Tsai M-J. Mouse retinoid X receptor β contains a separable ligand-binding and transactivation domain in its E region. Mol Cell Biol. 15:1995;255-263.
24. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:1994;5370-5382.
25. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA, Glass CK. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature. 371:1994;528-531.
26. Forman BM, Umesono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. of outstanding interest Cell. 81:1995;541-550 Another report investigating the ligand binding properties of RXR in several heterodimeric contexts. It is shown that RXR-selective ligands can activate RXR/NURR1 heterodimers, suggesting the existence of novel retinoid pathways.
27. Kersten S, Dawson MI, Lewis BA, Noy N. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently. of outstanding interest Biochemistry. 35:1996;3816-3824 Using fluorescence-based methods, the authors show that RXR and RAR, when heterodimerized, are both able to bind to their respective ligands either in solution or when bound to target DNA. These findings are in contrast to other reports [25, 26] where (by using different methods, i.e. GST-receptor ligand pull-down assays) binding of a synthetic ligand to RXR was inhibited by RAR in the presence of target DNA.
28. Apfel C, Kamber M, Klaus M, Mohr P, Keidel S, LeMotte PK. Enhancement of HL-60 differentiation by a new class of retinoids with selective affinity on retinoid X receptor. J Biol Chem. 270:1995;30765-30772.
29. Lotan R, Dawson MI, Zou C-C, Jong L, Lotan D, Zou C-P. Enhanced efficiency of combinations of retinoic acid and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 55:1995;232-236.
30. Nagy L, Thomázy VA, Shipley G, Fesüs L, Lamph W, Heyman RA, Chandraratna RA, Davies PJ. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol. 15:1995;3540-3551.
31. Roy B, Taneja R, Chambon P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α(RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol. 15:1995;6481-6487.
32. Xiao J-H, Durand B, Chambon P, Voorhees JJ. Endogenous RAR/RXR heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. J Biol Chem. 270:1995;3001-3011.
33. Yang Y, Minucci S, Ozato K, Heyman RA, Ashwell JD. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem. 270:1995;18672-18677.
34. Brooks SC III, Kazmer S, Levin AA, Yen A. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood. 87:1996;227-237.
35. Horn V, Minucci S, Ogryzko V, Adamson E, Howard B, Levin A, Ozato K. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J. 10:1996;1071-1077.
36. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
37. Perlmann T, Jansson L. A novel pathway for Vitamin A signaling mediated by RXR heterodimerization with NGFIB and NURR1. of special interest Genes Dev. 9:1995;769-782 A detailed analysis of the interaction of RXR with the orphan receptors NGFI-B and NURR1. Interestingly, canonical RAREs are shown to be activated by RXR/NGFI-B heterodimers and this activation is dependent on ligand binding to RXR.
38. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. of special interest Genes Dev. 9:1995;1033-1045 Cloning of the gene for LXR, a novel orphan receptor that heterodimerizes with RXR and is activated by RXR-selective ligands. The DNA target for activated efficiently by RXR/TR heterodimers.
39. Forman B, Goode E, Chen J, Oro A, Bradley DJ, Perlmann T, Noonan D, Burka LT, McMorris T, Lamph WW, Evans RM. Identification of a nuclear receptor that is activated by farnesol metabolites. of special interest Cell. 81:1995;687-693 Cloning of the gene for the farnesoid receptor, that binds to farnesol metabolites produced in the mevalonate pathway leading to the synthesis of cholesterol, steroids, and several key signalling molecules.
40. Schulman IG, Chakravarti D, Juguilon H, Romo A, Evans RM. Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc Natl Acad Sci USA. 92:1995;8288-8292.
41. Blanco J, Wang IM, Tsai SY, Tsai MJ, OMalley BW, Jurutka P, Haussler MR, Ozato K. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA. 92:1995;1535-1539.
42. Hazdic E, Desai-Yajnik V, Helmer E, Guo S, Wu S, Koudinova N, Casanova J, Raaka BM, Samuels HH. A 10-amino acid sequence in the N-terminal A/B/ domain of thyroid hormone receptor α is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol Cell Biol. 15:1995;4507-4517.
43. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell. 57:1989;433-442.
44. Horlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. of outstanding interest Nature. 377:1995;397-403 Cloning of genes for NCoR, co-repressor for RAR, TR and potentially other receptors. In this report (and [45]) the association of NCoR (and SMRT, see below) with RAR and TR is shown to be critical for receptor-mediated repression in the absence of ligand.
45. Chen D, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. of outstanding interest Nature. 377:1995;454-457 This report details the cloning of the gene for another co-repressor, SMRT; the sequence homology with NCoR suggests the presence of families of co-repressors with possible distinct functions.
46. Kurokawa R, Soderstrom M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. of special interest Nature. 377:1995;451-454 NCoR is not released from RAR bound on a DR1 element, providing a possible mechanism of the lack of activation via this element.
47. Saatclogiu F, Claret FX, Karin M. Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol. 5:1994;347-359.
48. Fondell JB, Brunel F, Hisatake K, Roeder RG. Unliganded thyroid hormone receptor α can target TATA-binding protein for transcription repression. of special interest Mol Cell Biol. 16:1996;281-287 Using biochemical approaches and in vitro transcription systems, the autors show that TBP might represent a direct target for the transcriptional repression mediated by TR in the absence of ligand.
49. Cavailles V, Dauvois S, Danielian PS, Parker MG. Interaction of proteins with transcriptionally active estrogen receptor. Proc Natl Acad Sci USA. 91:1994;10009-10013.
50. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. of special interest EMBO J. 14:1995;3741-3751 The initial characterization of RIP140, a protein that binds to the estrogen receptor in a ligand-dependent fashion. RIP140 is shown to weakly modulate the transcriptional activity of ER by estrogen but not by anti-estrogens.
51. Halachmi S, Marden E, Martin G, MacKay I, Abbondanza C, Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 264:1994;1455-1458.
52. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R. The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. of special interest EMBO J. 14:1995;2020-2033 A yeast genetic screen was used to clone TIF1, protein with 1017 residues. The amino-terminal region of TIF1 is fused to B-raf in the mouse oncoprotein T18.
53. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. Interaction of thyroid hormone receptor with a conserved transcriptional mediator. of special interest Nature. 371:1995;91-94 The yeast two-hybrid system was used to isolate Trip 1, a human factor that interacts with TR and RXR in a ligand-dependent manner and that is homologous to the yeast factor SUG1.
54. Oñate SA, Tsai M-J, O'Malley BW. Sequence and characterization of a coativator for the steroid hormone receptor superfamily. of special interest Science. 270:1995;1354-1357 Cloning of the gene for SRC-1, a co-activator for several classes of transcription factors, including nuclear receptors. The functional studies presented in this report show a clear increase in ligand-dependent transcriptional capacity to all the nuclear receptors tested and are the best example of a transcriptional coactivator for the members of the superfamily.
55. Von Baur E, Zechel C, Heery D, Heine MJS, Garnier J-M, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. of special interest EMBO J. 15:1996;110-124 Analysis of the interaction of several nuclear receptors with two putative co-activators mSUG1 and TIF1. The receptors show marked differences in their interaction with these two factors, suggesting that differential receptor-co-activator interactions may take place in vivo.
56. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. of outstanding interest Cell. 85:1996;403-414 CBP, originally defined as a co-activator for the CREB family of transcription factors, is shown to modulate activities of RXR and RAR.
57. Pfahl M. Nuclear receptors/AP-1 interactions. Endocr Rev. 14:1993;651-658.
58. Arany Z, Sellers WR, Livingston DM, Eckner R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell. 77:1994;799-800.
59. Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizers with other receptors. of special interest Science. 272:1996;1336-1339 Cloning SHP, a natural dominant negative member of the nuclear receptor superfamily. The possibility of a negative control of the function of several receptors by SHP deserves to be carefully explored.
60. Muchardt C, Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SW12 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12:1993;4279-4290.
61. Yoshinaga SK, Peterson C, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3 proteins for trancriptional enhancement by steroid receptors. Science. 258:1992;1598-1604.
62. Minucci S, Zand DJ, Dey A, Marks MS, Nagata T, Grippo JF, Ozato K. Dominant negative retinoid X receptor β inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells. Mol Cell Biol. 14:1994;360-372.
63. Dey A, Minucci S, Ozato K. Ligand-dependent occupancy of the retinoic acid receptor-β2 promoter in vivo. Mol Cell Biol. 12:1994;3590-3599.
64. Blanco JC, Dey A, Leid M, Minucci S, Park BK, Jurutka P, Haussler M, Ozato K. Inhibition of ligand-induced promoter occupancy in vivo by a dominant negative RXR. of special interest From Genes to Cell. 1:1996;209-221 In this report, stably transfected P19 cell clones expressing a mutated RXR that lacks the AF-2 region are shown to be defective in ligand-induced in vivo occupancy of the RARβ2 promoter, suggesting that the AF-2 region of RXR plays a role in receptor - DNA interactions in vivo.
65. Minucci S, Botquin V, Yeom YI, Dey A, Sylvester I, Zand DJ, Ohbo K, Ozato K, Schöler HR. Retinoic acid-mediated down-regulation of in vivo. of special interest EMBO J. 15:1996;888-899 Genomic footprinting analysis of the Oct3/4 promoter, that is downregulated by retinoids in embryonal carcinoma and embryonic stem cells. In the absence of RA, when the RA is expressed, several sites crucial for expression are occupied in vivo. Upon RA addition, factors are displaced from the promoter, coinciding with the transcriptional downregulation of the gene.
66. Restinejad F, Perlmann T, Evans RM, Sigler PB. Structural repeats. of outstanding interest Nature. 375:1995;203-211 A report detailing the X-ray structure of the DBDs of RXR and TR bound to a DR4 response element. The DBDs are assembled in a polar way, with the RXR DBD occupying the 5' half-site.
67. Chen J-Y, Clifford J, Zusi C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P, Gronemeyer. Two distinct actions of retinoid-receptor ligands. Nature. 382:1996;819-822.